Sentences with phrase «of therapeutic outcomes»

Six - month follow - up of two mother — infant psychotherapies: Convergence of therapeutic outcomes

Six - month follow - up of two mother - infant psychotherapies: Convergence of therapeutic outcomes.

I believe the source of therapeutic outcomes lie within the individual.

Cohen N., Muir E., Lojkasek M., Muir R. and Parker C. [2002] Six - month follow - up of two mother - infant psychotherapies: Convergence of therapeutic outcomes.

Measures used included the Schedule of Affective Disorders and Schizophrenia for School - Age Children (K - SADS), the Child PTSD Symptom Scale — Interview (CPSS - I), the Child PTSD Symptom Scale — Self - Report (CPSS - SR), the Children's Depression Inventory (CDI), The Children's Global Assessment Scale (CGAS), and the Expectancy of Therapeutic Outcome for Adolescents (ETO - A).

Not exact matches

This press release contains forward - looking statements, including expectations regarding adjudication of MACE events, results and related timing and announcements with respect to Amarin's REDUCE - IT cardiovascular outcomes study; expectations related to the final outcomes of the REDUCE - IT study and the anticipated successful completion of the REDUCE - IT study; and statements regarding the potential and therapeutic benefits of Vascepa.

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

Four motifs in Rogers» approach to counseling and therapy represent continuing contributions to the psychotherapeutic enterprise — his growth orientation; his emphasis on listening responsively and acceptingly to clients; his awareness that the emotional quality of the therapeutic relationship is the key to whether or not it nurtures growth; and his commitment to subjecting the therapeutic process and outcome to careful research.

Thus, although improving the economic status of families promotes more positive outcomes for children's cognitive development and academic achievement, direct services and therapeutic interventions may be a comparatively more promising alternative for improving children's psychosocial development and reducing behaviour problems.

• Addressing latch issues immediately to prevent nipple pain and early weaning • Differentiating between Raynaud's Phenomenon of the Nipple and Candidiasis as a cause of pain • Evidence - based treatment strategies for painful nipples • Lanolin use and possible increased risk of nipple or breast infection • Topical treatments used by mothers for nipple pain and trauma • Frenotomy to decrease breastfeeding difficulties due to ankyloglossia • Timing of frenotomy for improved breastfeeding and infant outcomes • Kinesio Elastic Therapeutic Taping ® in treating breast engorgement • Mothers» subjective experience of nipple pain and breastfeeding difficulties

Discuss how to choose an intervention to promote a desired observable outcome from play therapy, given a specified therapeutic power of play and trait of play.

«Clinical» hypnosis and «pastoral» hypnotherapy do imply a clinical or pastoral setting, with the focus more on the process of communication and therapeutic outcome, rather than on the hypnotic state involved.

«These results should enable predictions of better clinical outcomes with therapeutic nonsense suppression,» the researchers write in their paper.

«By administering chemotherapy within this «therapeutic window,» oncologists could apply a lower dose of chemotherapy drugs to patients, with the potential for an improved treatment outcome — all while minimizing drug toxicity to healthy organs,» He said.

In anticipation of targeted medicines, pharmaceutical and biotechnology companies are increasingly performing genetic studies of clinical trial participants in hopes of identifying genetic profiles that predict therapeutic outcomes.

«Despite the intense therapeutic and surgical regimen typically used to treat ovarian cancer, outcomes remain poor,» said William Small Jr., MD, chair, Department of Radiation Oncology, LUHS.

«New therapeutic strategies that target the molecular drivers of invasion are required for improved clinical outcome,» said Dr. Harshil Dhruv, a TGen Research Assistant Professor and lead author of the study.

The study, which will be published December 21 in the Journal of Cell Biology, suggests that the loss of these particular Numb proteins makes breast cancers more aggressive and resistant to chemotherapy, but points the way toward new therapeutic approaches that could improve patient outcome by preserving p53 levels.

«These are the best - done and largest assessments of how the microbiome may influence therapeutic outcome» from those drugs, says immunotherapy researcher Jeffrey Weber of New York University in New York City, who was not involved in the studies.

The paper, by S.S. Karuppagounder at Burke Medical Research Institute in White Plains, N.Y., and colleagues was titled, «Therapeutic targeting of oxygen - sensing prolyl hydroxylases abrogates ATF4 - dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models.»

Interestingly, the team showed that combining anti-angiogenic and immune - stimulating therapies in the treatment of tumors in mouse models resulted in better therapeutic outcomes by providing white blood cell gates through which they can infiltrate cancers.

«Use of therapeutic hypothermia and outcomes following in - hospital cardiac arrest.»

«The findings open new therapeutic avenues, particularly for the Group 3 and 4 subtypes where patient outcomes are inferior for the majority of affected children.»

Because chronic hyperglycemia... potentially predicts a poor therapeutic effect of aerobic exercise on glycemic control and fitness, using exercise to treat patients with poorly controlled T2DM may have limited chances of a successful outcome,» the study concludes.

«The progression of cancer to the metastatic stage represents a pivotal event that influences patient outcomes and the therapeutic options available to patients,» said senior author Pandolfi.

In addition to her expert skill as a clinician, Dr. Frontera also has many research interests including identifying biomarkers and predictors of early brain injury and vasospasm / delayed cerebral ischemia after subarachnoid hemorrhage and their impact on outcome; determining the efficacy of therapeutic strategies and developing guidelines for the management of patients with intracranial hemorrhage; evaluating the cost, length of stay, quality of life, functional and cognitive outcomes in a broader population of intracranial hemorrhage patients; developing guidelines for the integration of palliative care into the intensive care unit setting; and evaluating the relationship of Zika virus infection, Guillain - Barre, and other neurologic disorders.

We hope that these efforts will allow us to identify means by which the response of iNKT cells can be manipulated to effect desired immunologic outcomes in possible therapeutic applications.

Dr Forrest is the Kessler site director of the NeuroRecovery Network (NRN), a network of six specialized rehabilitation centers that translates evidence - based, activity - dependent therapeutic interventions into the clinic and evaluates them using comprehensive standardized outcomes.

While translational research has traditionally moved basic immunology knowledge forward into clinical application, varying clinical presentations of human immune - related disease processes, as well as variability in therapeutic outcomes, have provided opportunities for discovery of novel mechanistic hypotheses directly from patients.

Notwithstanding, there are still barriers (scientific, economic, educational, ethical, legal) that need to be overcome prior to the application of pharmacogenomic technologies towards innovative clinical strategies and optimized therapeutic outcomes.

Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications.

«The findings open new therapeutic avenues, particularly for the Group 3 and 4 subtypes, where patient outcomes are inferior for the majority of affected children,» said Paul Northcott, PhD, of St. Jude Developmental Neurobiology.

In general, genetic polymorphisms result in alterations of pharmacokinetic and / or pharmacodynamics properties which are then reflected in therapy outcomes that range from potentially life - threatening adverse effects to inadequate therapeutic response.

One secondary outcome will be immunogenicity, meaning monitoring subjects for any emergence of antibodies against the infused therapeutic antibodies themselves; additionally, «Multiple clinical and exploratory biomarkers will be assessed» in the Phase Ib trial.

«PROs supplement clinical outcomes and provide a holistic understanding of patient experience and treatment effectiveness, and help inform therapeutic choices, disease management practices, reimbursement decisions, and health policy,» said Dirk Schadendorf, MD, director of the department of dermatology at the University Hospital Essen in Essen, Germany.

The significant difference in outcome achieved by transplantation of hGDAsBMP versus hGDAsCNTF demonstrates clearly that not all astrocytes are equivalent in respect to their therapeutic value, and this appears to be the first study demonstrating functional differences between different human astrocyte populations with respect to repairing the adult central nervous system.

One outcome of such studies might be the development of novel biomarkers of disease states, adverse responses, beneficial responses, exposures, or therapeutic responses.

â $ œFor the first time, a clinical trial has shown that administration of a cellular therapeutic results in an improvement in cardiac outcomes based on a prespecified analysis, â $ an editorial accompanying the paper in The Lancet says.

Their work points to opportunities for therapeutic interventions — even in the first few weeks of life — that might improve long - term outcomes for the preemies.

Dr. Lanteri is also interested in using the OMICS approach to identify predictive markers of disease outcome and new therapeutic targets.

In 1954, an era where only 5 % of patients with Hodgkin lymphoma survived, Drs. Henry Kaplan and Edward Ginzton invented the first medical linear accelerator in the Western Hemisphere to deliver therapeutic radiotherapy (RT) with improved accuracy and potency, leading to curative outcomes in a group of patients with Hodgkin lymphoma.

Hence we are initiating a new paradigm for patient stratification based on modelling multi-level patient phenotypes, which could beneficially influence patient outcomes by improving optimisation of therapeutic strategies.

The extraordinary and welcome growth in interest in novel therapeutic platforms, including in cell based immunotherapies, has the potential to transform patient outcomes in a range of acute and chronic diseases.

Breast cancer is a heterogeneous disease with a high degree of diversity in histology, therapeutic response, and treatment outcomes.

The ECOG - ACRIN Cancer Research Group contains an Imaging Core Laboratory to support a wide range of clinical trials associated with imaging that are developed across the Group's three scientific programs: Cancer Control and Outcomes, Therapeutic Studies, and Biomarker Sciences.

Recently, more researchers have applauded self - massage, in particular, with a new study published in the International Journal of Therapeutic Massage Bodywork finding that it significantly improves the outcome of those with osteoarthritis of the knee.

However, far from encouraging people to consume unhealthy fats, this promising outcome may result in new therapeutic uses of Incas» peanut for the treatment of both hypertriglyceridemia and type 2 diabetes, as well as in new ways of preventing cardiovascular and metabolic diseases.

With any therapeutic interaction it is the combination of the therapist's knowledge of his tools and his ability to see and understand the person with whom he is interacting that will determine the outcome of the therapy.

These interventions include nutrition, culinary techniques, physical activity, and stress management approaches of therapeutic yoga and behavioral health coaching to improve outcomes for patients at risk and those who already have common chronic diseases.

Class IV lasers are a non-invasive, drug - free solution that offers better patient outcomes in a myriad of surgical and therapeutic applications.